Dr. Ebot Eyong is a proven senior consultant in regulatory affairs and quality assurance engineering for advanced Medtech, Biotech, and pharmaceutical product development. A result-oriented biomedical engineer and regulatory affairs leader with 20 years of experience in global quality and regulatory strategy, compliance, and regulatory submissions (510K, PMA, IDE, EUMDR/IVDR, CTAs, IND, NDA, BLA, eCTD 4.0, etc.). As a senior principal consultant for E&E Medicals and Consulting, he has dedicated his career to working with the major stakeholders in the healthcare industry with an exceptional record of gaining regulatory approvals and clearances for new products in existing and emerging markets (AMERS, APAC, LATAM, EMEA, ASEAN, META). Managing remediation activities involving observations/warning letters/recall actions, including cross-functional communication and delegation of responsibilities across stakeholders and executing streamlined deliverables at competitive levels. Dr. Eyong earned his doctorate in engineering management from Walden University and postdoctoral studies in digital health and data science applications at Harvard Medical School. Dr. Eyong’s newest book, titled MED-CHAINS & COVID-19: Innovative Solutions for Pandemics, a thoroughly researched approach to pandemics, employs the expertise of respected medical researchers, acclaimed scientists, and innovative medical device and drug developers across the industry.
website: http://eyongee.com
—————————————-
Currently running and some completed projects:
** Integra LifeSciences, USA
Advising senior regulatory affairs executives on decision-making and strategy on regulatory pathways/submissions for fast-track product clearances and approvals into global markets.
** Baxter International, USA
SME in developing and implementing regulatory strategies for assigned programs (Global & EU MDR Labeling and RA Submissions), ensuring cross-functional alignment to regulatory compliance and deficiencies.
** ZOLL Medical Corporation, USA
Managed the original PMA submission (180 days) to approve the LifeVest Wearable Defibrillator in a record timeframe.
** Autem Therapeutics, USA
Managed design controls per ISO requirements to resolve regulatory issues.
** Knoell USA,
Reviewed design and change controls, leading discussions with regulatory bodies, preparing and supporting timely submissions/approvals and resolving regulatory compliance issues.
** Philips Healthcare, USA
Subject Matter Expert (SME) in Managing Worldwide Regulatory Compliance Requests and Submissions on Remediation of Medical Devices.



MED-CHAINS – “A Groundbreaking Exploration of Pandemics”
Med-Chains is about the interrelationships and challenges faced by countries in finding solutions during pandemics. The effects of disruptions within the healthcare system and the activities that lead to shortages in medical supplies, regulatory challenges, government interventions, re-engineering, and geo-economic consequences during a pandemic are relatively connected.
This publication will feature opinions from leaders of the healthcare industry, across the public and private sphere, including Presidents, Government Ministers, IHOs, CEOs, Scientists, and independent minds across Med-Chains. It includes, resources, opinion pieces, and essential data needed in solving pandemics.
The book is published in ten languages – English, French, Spanish, German, Portuguese, Chinese, Russian, Arabic, Latin, and Japanese
**************************************************************************************************************************************************************************
Now Available In Ebook, Paperback, And Audiobook
Now Available At These Retailers

What do stress and the coronavirus have in common?
The COVID-19 pandemic changed the way we work fundamentally. Suddenly we had to take an invisible enemy into account and respect several precautions to minimize
This book will be available in ten languages: English, French, Spanish, German, Portuguese, Chinese, Russian, Arabic, Latin, and Japanese. Let us start the conversation……
“All proceeds from the book will go to charities that help kids who lost a parent during this pandemic.”